| nr |
titel |
auteur |
tijdschrift |
jaar |
jaarg. |
afl. |
pagina('s) |
type |
| 1 |
An Automation System Equivalent to the Douglas Bag Technique Enables Continuous and Repeat Metabolic Measurements in Patients Undergoing Mechanical Ventilation
|
Shinozaki, Koichiro
|
|
|
44 |
11 |
p. 1471-1479
|
artikel
|
| 2 |
Assessing the Cost-effectiveness of a Hypothetical Disease-modifying Therapy With Limited Duration for the Treatment of Early Symptomatic Alzheimer Disease
|
Boustani, Malaz
|
|
|
44 |
11 |
p. 1449-1462
|
artikel
|
| 3 |
Bilateral Effect of OC-01 (Varenicline Solution) Nasal Spray for Treatment of Signs and Symptoms in Individuals with Mild, Moderate, and Severe Dry Eye Disease
|
Katz, James
|
|
|
44 |
11 |
p. 1463-1470
|
artikel
|
| 4 |
Characteristics of Real-world Commercially Insured Patients With Treatment-resistant Depression Initiated on Esketamine Nasal Spray or Conventional Therapies in the United States
|
Karkare, Swapna
|
|
|
44 |
11 |
p. 1432-1448
|
artikel
|
| 5 |
Editorial Board
|
|
|
|
44 |
11 |
p. ii-iii
|
artikel
|
| 6 |
Effects of a Pharmacist-Led Educational Interventional Program on Electronic Monitoring–assessed Adherence to Direct Oral Anticoagulants: A Randomized, Controlled Trial in Patients with Nonvalvular Atrial Fibrillation
|
Shiga, Tsuyoshi
|
|
|
44 |
11 |
p. 1494-1505
|
artikel
|
| 7 |
Efficacy and Safety of the Remimazolam-Alfentanil Combination for Sedation During Gastroscopy: A Randomized, Double-blind, Single-center Controlled Trial
|
Shi, Wenyan
|
|
|
44 |
11 |
p. 1506-1518
|
artikel
|
| 8 |
Efficacy and Tolerability of Insulin Degludec Versus Other Long-acting Basal Insulin Analogues in the Treatment of Type 1 and Type 2 Diabetes Mellitus: A Systematic Review and Meta-analysis
|
Dong, Zhi-Yuan
|
|
|
44 |
11 |
p. 1520-1533
|
artikel
|
| 9 |
More Thoughts About Boswellia serrata
|
Shader, Richard I.
|
|
|
44 |
11 |
p. 1546-1547
|
artikel
|
| 10 |
Strong Pharmacokinetic Drug-Drug Interactions With Drugs Approved by the US Food and Drug Administration in 2021: Mechanisms and Clinical Implications
|
Yu, Jingjing
|
|
|
44 |
11 |
p. 1536-1544
|
artikel
|
| 11 |
Table of Contents
|
|
|
|
44 |
11 |
p. iv-v
|
artikel
|
| 12 |
Use of Resource Modeling to Quantify the Organizational Impact of Subcutaneous Formulations for the Treatment of Oncologic Patients: The Case of Daratumumab in Multiple Myeloma
|
Federici, Carlo
|
|
|
44 |
11 |
p. 1480-1493
|
artikel
|
| 13 |
When Still Water Runs Deep: The Complexities of Clinically Repurposing FDA Approved Therapies
|
Beninger, Paul
|
|
|
44 |
11 |
p. 1427-1430
|
artikel
|
Tijdschrift beschrijving